Holz Olaf, Seiler Tanja, Karmeier Andreas, Fraedrich Jan, Leiner Helmut, Magnussen Helgo, Jörres Rudolf A, Welker Lutz
Hospital Grosshansdorf, Center for Pneumology and Thoracic Surgery, 22927 Grosshansdorf, Germany.
BMC Pulm Med. 2008 Feb 28;8:5. doi: 10.1186/1471-2466-8-5.
The assessment of airway inflammation for the diagnosis of asthma or COPD is still uncommon in pneumology-specialized general practices. In this respect, the measurement of exhaled nitric oxide (NO), as a fast and simple methodology, is increasingly used. The indirect assessment of airway inflammation, however, does have its limits and therefore there will always be a need for methods enabling a direct evaluation of airway inflammatory cell composition. Sampling of spontaneous sputum is a well-known, simple, economic and non-invasive method to derive a qualitative cytology of airway cells and here we aimed to assess today's value of spontaneous sputum cytology in clinical practice.
Three pneumologists provided final diagnoses in 481 patients having sputum cytology and we retrospectively determined posterior versus prior probabilities of inflammatory airway disorders. Moreover, in a prospective part comprising 108 patients, pneumologists rated their confidence in a given diagnosis before and after knowing sputum cytology and rated its impact on the diagnostic process on an analogue scale.
Among the 481 patients, 45% were diagnosed as having asthma and/or airway hyperresponsiveness. If patients showed sputum eosinophilia, the prevalence of this diagnosis was elevated to 73% (n = 109, p < 0.001). The diagnosis of COPD increased from 40 to 66% in patients with neutrophilia (n = 29, p < 0.01).Thirty-three of the 108 patients were excluded from the prospective part (26 insufficient samples, 7 incomplete questionnaires). In 48/75 cases the confidence into a diagnosis was raised after knowing sputum cytology, and in 15/75 cases the diagnosis was changed as cytology provided new clues.
Our data suggest that spontaneous sputum cytology is capable of assisting in the diagnosis of inflammatory airway diseases in the outpatient setting. Despite the limitations by the semiquantitative assessment and lower sputum quality, the supportive power and the low economic effort needed can justify the use of this method, particularly if the diagnosis in question is thought to have an allergic background.
在肺科专科普通门诊中,通过评估气道炎症来诊断哮喘或慢性阻塞性肺疾病(COPD)仍不常见。在这方面,作为一种快速简便的方法,呼出一氧化氮(NO)的测量越来越多地被采用。然而,气道炎症的间接评估确实存在局限性,因此始终需要能够直接评估气道炎症细胞组成的方法。自行咳痰采样是一种众所周知的、简单、经济且无创的方法,可用于获取气道细胞的定性细胞学信息,我们旨在评估目前自行咳痰细胞学检查在临床实践中的价值。
三位肺科医生对481例进行了痰液细胞学检查的患者给出了最终诊断,我们回顾性地确定了炎症性气道疾病的后验概率与先验概率。此外,在一个包含108例患者的前瞻性研究中,肺科医生在知晓痰液细胞学检查结果之前和之后对给定诊断的信心进行评分,并在模拟量表上对其对诊断过程的影响进行评分。
在481例患者中,45%被诊断为患有哮喘和/或气道高反应性。如果患者痰液中嗜酸性粒细胞增多,该诊断的患病率则升至73%(n = 109,p < 0.001)。中性粒细胞增多的患者中,COPD的诊断率从40%升至66%(n = 29,p < 0.01)。108例患者中有33例被排除在前瞻性研究之外(2位患者样本不足,7位患者问卷不完整)。在48/75例病例中,知晓痰液细胞学检查结果后对诊断的信心增强,在15/75例病例中,由于细胞学检查提供了新线索,诊断发生了改变。
我们的数据表明,自行咳痰细胞学检查能够在门诊环境中辅助诊断炎症性气道疾病。尽管存在半定量评估的局限性和较低的痰液质量,但该检查的支持作用以及所需的低经济成本证明了这种方法的使用合理性,特别是当所考虑的诊断被认为具有过敏背景时。